- Home
- JNVR vs NLSP Comparison
JNVR vs NLSP Comparison
Compare JNVR & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JNVR
- NLSP
- Stock Information
- Founded
- JNVR 2018
- NLSP 2015
- Country
- JNVR United States
- NLSP Switzerland
- Employees
- JNVR N/A
- NLSP N/A
- Industry
- JNVR Finance: Consumer Services
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- JNVR Finance
- NLSP Health Care
- Exchange
- JNVR Nasdaq
- NLSP Nasdaq
- Market Cap
- JNVR N/A
- NLSP 243.8M
- IPO Year
- JNVR 2023
- NLSP 2021
- Fundamental
- Price
- JNVR $0.55
- NLSP $4.96
- Analyst Decision
- JNVR
- NLSP
- Analyst Count
- JNVR 0
- NLSP 0
- Target Price
- JNVR N/A
- NLSP N/A
- AVG Volume (30 Days)
- JNVR 21.7K
- NLSP 34.6K
- Earning Date
- JNVR 11-12-2024
- NLSP 11-01-2024
- Dividend Yield
- JNVR N/A
- NLSP N/A
- EPS Growth
- JNVR N/A
- NLSP N/A
- EPS
- JNVR N/A
- NLSP N/A
- Revenue
- JNVR $1,786,085.00
- NLSP N/A
- Revenue This Year
- JNVR N/A
- NLSP N/A
- Revenue Next Year
- JNVR N/A
- NLSP N/A
- P/E Ratio
- JNVR N/A
- NLSP N/A
- Revenue Growth
- JNVR N/A
- NLSP N/A
- 52 Week Low
- JNVR $0.42
- NLSP $4.08
- 52 Week High
- JNVR $1.84
- NLSP $29.68
- Technical
- Relative Strength Index (RSI)
- JNVR 49.64
- NLSP 46.37
- Support Level
- JNVR $0.49
- NLSP $4.52
- Resistance Level
- JNVR $0.62
- NLSP $5.64
- Average True Range (ATR)
- JNVR 0.06
- NLSP 0.48
- MACD
- JNVR -0.00
- NLSP 0.07
- Stochastic Oscillator
- JNVR 58.69
- NLSP 55.44
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.